Age-Dependent Decrease of DNA Hydroxymethylation in Human T Cells
Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba, Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba
Abstract
Hydroxymethylcytosine (hmC) is a natural nucleobase, which is converted from methylcytosine (mC) by tet methylcytosine dioxygenase (TET) family (TET1-3) enzymes. Decrease of genomic hmC is postulated to confer a risk for myeloid-lineage as well as T-cell neoplasms, based on the fact that loss-of-function mutations in the TET2 gene were frequently identified in these diseases. The relationship between hmC and aging remains to be elucidated. Here, we demonstrated that hmC content decreased with age in the peripheral blood T cells of 53 human volunteers. We further identified that the mRNA expression levels of TET1 and TET3 decreased with age, while those of TET2 were not influenced by age. The genomic hmC content was correlated with the mRNA expression level of TET3, but not those of TET1 and TET2. Our study suggests the presence of new epigenetic regulatory mechanisms in aging T cells.
Source: PubMed
Próximos ensayos clínicos
-
NCT07826949Aún no reclutandoGlioma | Neoplasia Cerebral | Gliomas recurrentes de alto grado
-
NCT07826962Aún no reclutandoCompromiso del paciente
-
NCT07826975Aún no reclutando
-
NCT07826988Aún no reclutandoAnemia drepanocítica | Crisis vaso-oclusiva
-
NCT07827001ReclutamientoCáncer de cerebro | Cáncer del SNC | Cáncer del sistema nervioso | Cáncer Cerebral Metastásico
-
NCT07827027Aún no reclutando
-
NCT07827040ReclutamientoAdultos | Asistencia digital para baja visión | Discapacidades Visuales
-
NCT07827053Aún no reclutandoAdenocarcinoma ductal pancreático (PDAC)
-
NCT07827066Aún no reclutandoDejar de fumar | Agente de IA | Early-Stage Cancer
-
NCT07827131Aún no reclutando